Alicia Uijl

Assistant professor

Netherlands

Research Interests

Explore related searches

Professors in Netherlands

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Dr. Alicia Uijl is an Assistant Professor at Amsterdam Cardiovascular Sciences, Amsterdam University Medical Centers, in the Netherlands. Her research focuses on cardiovascular health, exploring topics such as sex differences in acute coronary syndromes, statin therapy, and treatment strategies for heart failure. She has contributed to recent articles on the integration of health registries and statistical microdata, as well as the implications of multimorbidity in heart failure management.

Articles (17)

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Collaborators (19)

Mariachiara Di Cesare

Director (Professor)

University of Essex

UNITED KINGDOM

Alicia Uijl

Research Interests

Explore related searches

Contact this professor

About

Articles (17)

Sex Differences in Acute Coronary Syndromes: A Scoping Review Across the Care Continuum

Uptitration of statin therapy in women and men: a population-based cohort study

Koppeling van kwaliteitsregistraties en CBS-microdata in de zorg: mogelijkheden, uitdagingen en aanbevelingen

Sex differences in the intensity of statin prescriptions at initiation in a primary care setting.

Sex Differences in the Primary Prevention of Cardiovascular Diseases in a Dutch Primary Care Setting.

Simplification of a registry-based algorithm for ejection fraction prediction in heart failure patients: Applicability in cardiology centres of the Netherlands

Federated learning as a smart tool for research on infectious diseases

Multimorbidity in Heart Failure: Leveraging Cluster Analysis to Guide Tailored Treatment Strategies

Does Heterogeneity Exist in Treatment Associations with Renin-Angiotensin-System Inhibitors or Beta-blockers According to Phenotype Clusters in Heart Failure with Preserved Ejection Fraction?

Discovering Distinct Phenotypical Clusters in Heart Failure Across the Ejection Fraction Spectrum: a Systematic Review

Identifying distinct clinical clusters in heart failure with mildly reduced ejection fraction

Redefining clinical venous thromboembolism phenotypes: a novel approach using latent class analysis

Sex differences in the generalizability of randomized clinical trials in heart failure with reduced ejection fraction

Generalizability of randomized controlled trials in heart failure with reduced ejection fraction

Clinical presentation, disease course, and outcome of COVID-19 in hospitalized patients with and without pre-existing cardiac disease: a cohort study across 18 countries.

Cardiac resynchronization therapy with or without defibrillator in patients with heart failure.

Biomarker changes as surrogate endpoints in early-phase trials in heart failure with reduced ejection fraction

Collaborators (19)

Mariachiara Di Cesare

Monika Hollander

Benedikt Schrage

Sanne Peters

Miriam Sturkenboom

Robin W M Vernooij

Frieder Braunschweig

Chiara Bucciarelli-Ducci

Mariëlle C van de Veerdonk

Katja de With

N. Charlotte Onland-Moret

Fleur V Y Tjong

Folkert Wouter Asselbergs

Fabrice Martens

Michael Melin

Hans-Peter Brunner-La Rocca

Cecilia LInde

Lukas Tometten

Lina Benson

Make your next move.